Pure Global

Young-onset Colorectal Cancer Screening Based on Artificial Intelligence - Trial NCT06342622

Access comprehensive clinical trial information for NCT06342622 through Pure Global AI's free database. This phase not specified trial is sponsored by Renmin Hospital of Wuhan University and is currently Completed. The study focuses on Colorectal Cancer. Target enrollment is 11000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06342622
Completed
diagnostic test
Trial Details
ClinicalTrials.gov โ€ข NCT06342622
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Young-onset Colorectal Cancer Screening Based on Artificial Intelligence
Application of Artificial Intelligence for Young-onset Colorectal Cancer Screening Based on Electronic Medical Records

Study Focus

Colorectal Cancer

Using routine clinical data and machine learning models.

Observational

diagnostic test

Sponsor & Location

Renmin Hospital of Wuhan University

Wuhan, China

Timeline & Enrollment

N/A

Dec 01, 2023

Jan 25, 2024

11000 participants

Primary Outcome

The performance of machine learning screening models

Summary

In this study, we aimed to develop, internally and temporally validate the machine learning
 models to help screen YOCRC bansed on the retrospective extracted Electronic Medical Records
 (EMR) data.

ICD-10 Classifications

Malignant neoplasm of colon
Malignant neoplasm: Descending colon
Malignant neoplasm: Colon, unspecified
Malignant neoplasm: Ascending colon
Malignant neoplasm: Overlapping lesion of colon

Data Source

ClinicalTrials.gov

NCT06342622

Non-Device Trial